Trade CMPX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Compass Therapeutics, Inc. (CMPX) is trading at US$0.94, down 5.59% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$432.21M. Over the past 52 weeks, CMPX has traded between US$0.83 and US$6.88. On Syfe you can trade CMPX with $0 commission and add it to your watchlist.
| Previous close | US$0.99 |
|---|---|
| Market cap | US$432.21M |
| 52-week range | US$0.83 – US$6.88 |
| Volume | 4.43M |
| Exchange | US |
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.
Year: 2020
Compass Therapeutics, Inc. (CMPX) stock is trading at US$0.94, -5.59% from the previous close of US$0.99.
The market cap for Compass Therapeutics, Inc. (CMPX) stock is approximately US$432.21M.
The 52-week high for Compass Therapeutics, Inc. (CMPX) stock is US$6.88.
The 52-week low for Compass Therapeutics, Inc. (CMPX) stock is US$0.83.
Compass Therapeutics, Inc. (CMPX) does not currently pay a dividend.
Stay on top of CMPX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
